
- Pharmaceutical Technology-09-02-2013
- Volume 37
- Issue 9
XstalBio Introduces CentuRecon
CentuRecon enables dry formulations of therapeutic proteins to quickly be prepared for injection at high concentration.
CentuRecon, a patented reconstitution technology, decreases the preparation time of high concentration protein solutions from dry powder formulations and makes delivery faster and safer, according to the company. CentuRecon enables dry formulations of therapeutic proteins to quickly be prepared for injection at high concentration and produces foam-free solutions that maximize the deliverable dose. CentuRecon is compatible with standard lyophilized formulations and diluents and with normal vials, cartridges, or dual-chamber syringes. It can be used for very high concentration and/or viscous solutions that may need to be delivered with injection devices.
Articles in this issue
almost 13 years ago
The Importance of Continued Investment in R&Dalmost 13 years ago
FDA Works to Secure Drug Supply Chainalmost 13 years ago
Outsourcing Partnerships for CMC Developmentalmost 13 years ago
MF40 Automated Punch and Die Polishing Machinealmost 13 years ago
Quality by Design in APIsalmost 13 years ago
Connecting People, Science, and Regulationalmost 13 years ago
Effective and Efficient Weighing of Potent Compoundsalmost 13 years ago
EU Raises API Standards: A Curse in Disguise?almost 13 years ago
The Importance of Characterization in Biosimilars Developmentalmost 13 years ago
Omega Design Corporation Introduces LabelSync 450



